CGEM

CULLINAN THERAPEUTICS INC

CGEM·230031106·US·Common Stock·Healthcare - Biotechnology-13D/G

CGEM (CULLINAN THERAPEUTICS INC) is held by 97 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($63.2M), STATE STREET CORP ($36.2M), VANGUARD CAPITAL MANAGEMENT LLC ($35.3M). Net institutional sentiment: Mixed.

97
Holders
Avg rating(20 Elite)
$394.2M
Total Value
64% (103)
Fund Consensus
61 buying - 34 selling
CGEMSmart Money Verdict
View all
Held by 97 funds
20 elite
Who's Trading
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
InsiderMJMichaelson JenniferExercise 4K shMay 5, 2026
InsiderMJMichaelson JenniferSell $114KMay 5, 2026
InsiderMJMichaelson JenniferSell $3KMay 5, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderMJMichaelson JenniferSell $125KMar 5, 2026
ActivistKYKynam Capital Management, LP5.3%Mar 4, 2026
InsiderMJMichaelson JenniferSell $25KFeb 25, 2026
InsiderANAHMED NADIMSell $196KFeb 24, 2026
InsiderMJMichaelson JenniferSell $52KFeb 24, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.4M(+1.1%)$63.2M0.0%+49.57%
30
Increased
2.5M(+15.8%)$36.2M0.0%+28.33%
33
New
2.5M$35.3M0.0%+15.26%
40
Increased
2M(+4201.4%)$28.8M0.0%+16.19%
46
Unchanged
1.7M$24.2M0.2%+4.53%
0
Increased
1.4M(+5.1%)$19.4M0.0%-6.55%
30
Increased
1M(+153.3%)$14.9M0.0%+18.92%
45
Increased
906,028(+6.8%)$12.9M0.0%+45.41%
30
Increased
905,376(+151.4%)$12.9M0.0%+35.11%
45
Increased
805,700(+39.1%)$11.4M0.0%+65.47%
37
Decreased
589,483(-23.1%)$8.4M0.0%+57.93%
0
New
552,553$7.9M0.0%+15.26%
38
Increased
522,047(+10.9%)$7.4M0.0%+80.54%
30
Increased
516,724(+49.2%)$7.3M0.0%+62.10%
38
Decreased
455,449(-36.9%)$6.5M0.0%+78.17%
0
Increased
449,258(+6.5%)$6.4M0.0%-14.64%
29
Decreased
432,893(-0.8%)$6.2M0.0%-5.70%
0
Decreased
367,906(-37.3%)$5.2M0.0%+72.44%
0
Increased
360,874(+28.2%)$5.1M0.0%+98.45%
34
Decreased
346,582(-4.4%)$4.9M0.0%+12.40%
0

Showing 1-20 of 103

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used